Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 1,225 | 980 | 796 | 1,051 | 1,338 |
| Gross Profit | 1,225 | 980 | 796 | 1,051 | 1,338 |
| Operating Expenses | 11,561 | 10,609 | 12,142 | 11,379 | 9,961 |
| Operating Income | -10,336 | -9,629 | -11,346 | -10,328 | -8,623 |
| Interest Expense | 1,176 | 0 | 0 | 0 | 0 |
| Other Income | -19,649 | 6,082 | -3,144 | 14 | 9 |
| Pre-tax Income | -31,161 | -3,547 | -14,490 | -10,314 | -8,614 |
| Net Income Continuous | -31,161 | -3,547 | -14,490 | -10,314 | -8,614 |
| Net Income | $-31,161 | $-3,547 | $-14,490 | $-10,314 | $-8,614 |
| EPS Basic Total Ops | -0.86 | -0.10 | -0.40 | -0.28 | -0.24 |
| EPS Basic Continuous Ops | -0.86 | -0.10 | -0.40 | -0.28 | -0.24 |
| EPS Diluted Total Ops | -0.86 | -0.17 | -0.40 | -0.28 | -0.24 |
| EPS Diluted Continuous Ops | -0.86 | -0.06 | -0.40 | -0.28 | -0.24 |
| EBITDA(a) | $-10,115 | $-9,401 | $-11,116 | $-10,083 | $-8,397 |